107 related articles for article (PubMed ID: 30594698)
1. Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons.
Wei X; Nishi T; Kondou S; Kimura H; Mody I
Neuropharmacology; 2019 Apr; 148():11-20. PubMed ID: 30594698
[TBL] [Abstract][Full Text] [Related]
2. Synaptic and extrasynaptic plasticity in glutamatergic circuits involving dentate granule cells following chronic N-methyl-D-aspartate receptor inhibition.
He S; Shao LR; Wang Y; Bausch SB
J Neurophysiol; 2013 Mar; 109(6):1535-47. PubMed ID: 23255721
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific effect of prenatal alcohol exposure on N-methyl-D-aspartate receptor function in orbitofrontal cortex pyramidal neurons of mice.
Licheri V; Chandrasekaran J; Bird CW; Valenzuela CF; Brigman JL
Alcohol Clin Exp Res; 2021 Oct; 45(10):1994-2005. PubMed ID: 34523139
[TBL] [Abstract][Full Text] [Related]
4. 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.
Sun MY; Linsenbardt AJ; Emnett CM; Eisenman LN; Izumi Y; Zorumski CF; Mennerick S
Neuroscientist; 2016 Apr; 22(2):132-44. PubMed ID: 25628343
[TBL] [Abstract][Full Text] [Related]
5.
Trent S; Hall J; Connelly WM; Errington AC
eNeuro; 2019; 6(3):. PubMed ID: 31209152
[TBL] [Abstract][Full Text] [Related]
6. Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects.
Doan J; Defaix C; Mendez-David I; Gardier AM; Colle R; Corruble E; McGowan JC; David DJ; Guilloux JP; Tritschler L
Fundam Clin Pharmacol; 2023 Dec; 37(6):1119-1128. PubMed ID: 37161789
[TBL] [Abstract][Full Text] [Related]
7. Effects of Complete and Partial Loss of the 24S-Hydroxycholesterol-Generating Enzyme
Shu HJ; Ziolkowski LH; Salvatore SV; Benz AM; Wozniak DF; Yuede CM; Paul SM; Zorumski CF; Mennerick S
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540675
[TBL] [Abstract][Full Text] [Related]
8. Effects of CYP46A1 Inhibition on Long-Term-Depression in Hippocampal Slices
Popiolek M; Izumi Y; Hopper AT; Dai J; Miller S; Shu HJ; Zorumski CF; Mennerick S
Front Mol Neurosci; 2020; 13():568641. PubMed ID: 33192294
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Glycyrrhiza Polysaccharide on Human Cytochrome P450 46A1 in vitro and in vivo: Implications in Treating Neurological Diseases.
Du J; Chen Z; Chen X; Zhang J; Wang Y; Zhao T; Wang D; Wang C; Chen Y; Meng Q; Sun H; Liu K; Wu J
Curr Drug Metab; 2024 May; ():. PubMed ID: 38797896
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of GluN2B-containing NMDA receptors in early life combined with social stress in adulthood leads to alterations in prefrontal PNNs in mice.
Liang YR; Zhang XH
Sheng Li Xue Bao; 2024 Feb; 76(1):1-11. PubMed ID: 38444127
[TBL] [Abstract][Full Text] [Related]
11. CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.
Lerner AJ; Arnold SE; Maxfield E; Koenig A; Toth ME; Fortin B; Mast N; Trombetta BA; Denker J; Pieper AA; Tatsuoka C; Raghupathy S; Pikuleva IA
Alzheimers Res Ther; 2022 Dec; 14(1):198. PubMed ID: 36581878
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H).
Koike T; Yoshikawa M; Ando HK; Farnaby W; Nishi T; Watanabe E; Yano J; Miyamoto M; Kondo S; Ishii T; Kuroita T
J Med Chem; 2021 Aug; 64(16):12228-12244. PubMed ID: 34387987
[TBL] [Abstract][Full Text] [Related]
13. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
[TBL] [Abstract][Full Text] [Related]
14. 24S-hydroxycholesterol: Cellular effects and variations in brain diseases.
Sodero AO
J Neurochem; 2021 May; 157(4):899-918. PubMed ID: 33118626
[TBL] [Abstract][Full Text] [Related]
15. A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies.
Halford JJ; Sperling MR; Arkilo D; Asgharnejad M; Zinger C; Xu R; During M; French JA
Epilepsy Res; 2021 Aug; 174():106646. PubMed ID: 33940389
[TBL] [Abstract][Full Text] [Related]
16. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice.
Nishi T; Kondo S; Miyamoto M; Watanabe S; Hasegawa S; Kondo S; Yano J; Watanabe E; Ishi T; Yoshikawa M; Ando HK; Farnaby W; Fujimoto S; Sunahara E; Ohori M; During MJ; Kuroita T; Koike T
Sci Rep; 2020 Oct; 10(1):17081. PubMed ID: 33051477
[TBL] [Abstract][Full Text] [Related]
17. Neuro-oxysterols and neuro-sterols as ligands to nuclear receptors, GPCRs, ligand-gated ion channels and other protein receptors.
Wang Y; Yutuc E; Griffiths WJ
Br J Pharmacol; 2021 Aug; 178(16):3176-3193. PubMed ID: 32621622
[TBL] [Abstract][Full Text] [Related]
18. The Intersection of cerebral cholesterol metabolism and Alzheimer's disease: Mechanisms and therapeutic prospects.
Liu LC; Liang JY; Liu YH; Liu B; Dong XH; Cai WH; Zhang N
Heliyon; 2024 May; 10(9):e30523. PubMed ID: 38726205
[TBL] [Abstract][Full Text] [Related]
19. Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer's astrocytes.
Zhang X; Chen C; Liu Y
Alzheimers Res Ther; 2024 Mar; 16(1):63. PubMed ID: 38521950
[TBL] [Abstract][Full Text] [Related]
20. CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice.
Latorre-Leal M; Rodriguez-Rodriguez P; Franchini L; Nikolidakis O; Daniilidou M; Delac L; Varshney MK; Arroyo-García LE; Eroli F; Winblad B; Blennow K; Zetterberg H; Kivipelto M; Pacciarini M; Wang Y; Griffiths WJ; Björkhem I; Matton A; Nalvarte I; Merino-Serrais P; Cedazo-Minguez A; Maioli S
Sci Adv; 2024 Jan; 10(4):eadj1354. PubMed ID: 38266095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
